Alerts will be sent to your verified email
Verify Email
PGHL
|
Procter&Gamble Healt
|
Orchid Pharma
|
Max Healthcare Inst
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Domestic Sales Growth - YoY
|
54.51 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
33.88 % | -7.68 % | 4.82 % |
|
5yr average Equity Multiplier
|
2.59 | 0.59 | 1.88 |
|
5yr Average Asset Turnover Ratio
|
0.52 | 0.38 | 0.39 |
|
5yr Avg Net Profit Margin
|
34.2 % | -6.96 % | 7.89 % |
|
Price to Book
|
9.78 | 4.77 | 10.09 |
|
P/E
|
36.83 | 44.91 | 74.91 |
|
5yr Avg Cash Conversion Cycle
|
-144.61 Days | 49.91 Days | -161.11 Days |
|
Inventory Days
|
41.56 Days | 112.74 Days | 6.33 Days |
|
Days Receivable
|
27.36 Days | 105.72 Days | 28.86 Days |
|
Days Payable
|
155.82 Days | 255.1 Days | 246.72 Days |
|
5yr Average Interest Coverage Ratio
|
261.18 | 0.47 | 4.97 |
|
5yr Avg ROCE
|
17.15 % | -4.58 % | 7.07 % |
|
5yr Avg Operating Profit Margin
|
25.59 % | 10.74 % | 20.81 % |
|
5 yr average Debt to Equity
|
0.0 | -0.45 | 0.35 |
|
5yr CAGR Net Profit
|
-22.83 % | -7.77 % | n/a |
|
5yr Average Return on Assets
|
14.73 % | -2.51 % | 3.46 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
51.82 % | 69.84 % | 23.75 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -28.23 % | -46.71 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.73 % | 15.18 % | 7.5 % |
|
Procter&Gamble Healt
|
Orchid Pharma
|
Max Healthcare Inst
|
|
|---|---|---|---|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Drug Delivery Break-Up
|
Drug Delivery Break-Up
|
-
|
-
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|
